These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28420081)

  • 1. Spondyloarthritis: Matrix Metalloproteinasesas Biomarkers of Pathogenesis and Response to Tumor Necrosis Factor (TNF) Inhibitors.
    Moz S; Aita A; Basso D; Ramonda R; Plebani M; Punzi L
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28420081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy.
    Vandooren B; Kruithof E; Yu DT; Rihl M; Gu J; De Rycke L; Van Den Bosch F; Veys EM; De Keyser F; Baeten D
    Arthritis Rheum; 2004 Sep; 50(9):2942-53. PubMed ID: 15457463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spondyloarthropathy in inflammatory bowel disease patients on TNF inhibitors.
    Subramaniam K; Tymms K; Shadbolt B; Pavli P
    Intern Med J; 2015 Nov; 45(11):1154-60. PubMed ID: 26337851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infliximab counteracts tumor necrosis factor-α-enhanced induction of matrix metalloproteinases that degrade claudin and occludin in non-pigmented ciliary epithelium.
    Yamada H; Yoneda M; Inaguma S; Watanabe D; Banno S; Yoshikawa K; Mizutani K; Iwaki M; Zako M
    Biochem Pharmacol; 2013 Jun; 85(12):1770-82. PubMed ID: 23603294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers for diagnosis, monitoring of progression, and treatment responses in ankylosing spondylitis and axial spondyloarthritis.
    Reveille JD
    Clin Rheumatol; 2015 Jun; 34(6):1009-18. PubMed ID: 25939520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Unmet Needs in Spondyloarthritis.
    Poddubnyy D; Sieper J
    Curr Rheumatol Rep; 2019 Jul; 21(9):43. PubMed ID: 31302784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt/β-catenin signaling plays a key role in the development of spondyloarthritis.
    Xie W; Zhou L; Li S; Hui T; Chen D
    Ann N Y Acad Sci; 2016 Jan; 1364(1):25-31. PubMed ID: 26629686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy.
    De Rycke L; Vandooren B; Kruithof E; De Keyser F; Veys EM; Baeten D
    Arthritis Rheum; 2005 Jul; 52(7):2146-58. PubMed ID: 15986373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why is biologic therapy useful in spondyloarthritis? Knowledge from synovial immunopathologic studies of spondyloarthritis.
    Chou CT
    Int J Rheum Dis; 2012 Dec; 15(6):507-11. PubMed ID: 23253232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brief Report: Nonsteroidal Antiinflammatory Drug-Sparing Effect of Tumor Necrosis Factor Inhibitors in Early Axial Spondyloarthritis: Results From the DESIR Cohort.
    Moltó A; Granger B; Wendling D; Breban M; Dougados M; Gossec L
    Arthritis Rheumatol; 2015 Sep; 67(9):2363-8. PubMed ID: 26109532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor α inhibitors: a study of radiographic progression, inflammation on magnetic resonance imaging, and circulating biomarkers of inflammation, angiogenesis, and cartilage and bone turnover.
    Pedersen SJ; Sørensen IJ; Lambert RG; Hermann KG; Garnero P; Johansen JS; Madsen OR; Hansen A; Hansen MS; Thamsborg G; Andersen LS; Majgaard O; Loft AG; Erlendsson J; Asmussen KH; Jurik AG; Møller J; Hasselquist M; Mikkelsen D; Østergaard M
    Arthritis Rheum; 2011 Dec; 63(12):3789-800. PubMed ID: 22127697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulatory effects of etanercept on peripheral joint synovitis in the spondylarthropathies.
    Kruithof E; De Rycke L; Roth J; Mielants H; Van den Bosch F; De Keyser F; Veys EM; Baeten D
    Arthritis Rheum; 2005 Dec; 52(12):3898-909. PubMed ID: 16329106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metalloproteinases in Rheumatoid Arthritis: Potential Therapeutic Targets to Improve Current Therapies.
    Itoh Y
    Prog Mol Biol Transl Sci; 2017; 148():327-338. PubMed ID: 28662826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Matrix Metalloproteinase in Inflammation with a Focus on Infectious Diseases.
    Lee HS; Kim WJ
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Spondyloarthritis - the novel concept. An introduction to the diagnosis and treatment of axial spondyloarthritis].
    Kiltz U; Baraliakos X; Braun J
    Dtsch Med Wochenschr; 2012 Sep; 137(36):1745-7. PubMed ID: 22933197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower frequency of obstructive sleep apnea in spondyloarthritis patients taking TNF-inhibitors.
    Walsh JA; Duffin KC; Crim J; Clegg DO
    J Clin Sleep Med; 2012 Dec; 8(6):643-8. PubMed ID: 23243397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Matrix Metalloproteinases in Angiogenesis and Its Implications in Asthma.
    Bajbouj K; Ramakrishnan RK; Hamid Q
    J Immunol Res; 2021; 2021():6645072. PubMed ID: 33628848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there new hope for therapeutic matrix metalloproteinase inhibition?
    Vandenbroucke RE; Libert C
    Nat Rev Drug Discov; 2014 Dec; 13(12):904-27. PubMed ID: 25376097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1β, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: rationale for combination treatment during arthritis.
    Koenders MI; Marijnissen RJ; Devesa I; Lubberts E; Joosten LA; Roth J; van Lent PL; van de Loo FA; van den Berg WB
    Arthritis Rheum; 2011 Aug; 63(8):2329-39. PubMed ID: 21520013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation between tumor necrosis factor alpha and matrix metalloproteinases levels in serum of patients with rheumatic arthritis].
    Klimiuk PA; Sierakowski S; Chwiećko J
    Pol Merkur Lekarski; 2003 May; 14(83):410-2. PubMed ID: 12939814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.